LIVE
Login☆ WatchlistAPI Docs
Markets
NSE StocksBSE StocksF&ORates & G-SecsCurrenciesSectorsCommodities
News
Corporate AnnouncementsGovernment & PolicyFixed IncomeETFsFXAlt. InvestingEconomic Calendar
Sections
EconomicsTechFinancePoliticsWealth
Language
Englishहिन्दीગુજરાતીमराठी

COHANCE

NSEBSE
Cohance Lifesciences Limited
Healthcare· Pharmaceuticals & Biotechnology· INE03QK01018· Scrip: 543064
ENहिन्दीગુજરાતીमराठी
496.45
64.35 (+14.89%)
28/4/2026, 2:53:56 pm
NSE
496.45
64.35
+14.89%
BSE
360.60
3.25
+0.00%
2794876969051,11405-1907-1009-0410-3012-2402-1904-24
229 trading days · 1Y period
TODAY
Open444.45
High514.90
Low444.00
Prev Close432.10
Volume3.62Cr
Value₹1780.7Cr
L: 444.00H: 514.90
52 WEEK
Low266.70
High1,235.00
24% of 52W range
Info
Face Value₹1
Listed2020-03-09
ISININE03QK01018
SeriesA
BSE Scrip543064

Key Metrics

1D
+18.74%
1W
+10.64%
1M
+43.44%
3M
-3.54%
6M
-51.20%
Valuation
P/Sales11.15
Mkt Cap₹11687 Cr
Growth (QoQ)
Revenue+19.18%
PAT+1.60%
EPS+0.93%
Profitability
Dividend
Yield1.16%
Growth+400.00%
TTM Revenue
₹1048 Cr
TTM EBITDA
₹431 Cr
TTM PAT
₹279 Cr
TTM EPS
₹10.98
Rev/Share
₹27.4

Quarterly Financials

Revenue
EBITDA
PAT
EPS
0 Cr92 Cr185 Cr277 Cr369 Cr23-0323-0623-0923-1224-0324-0624-0924-124.94.73.11.82.12.43.23.3
QuarterRevenueExpensesEBITDAPBTPATEPS
2024-12-31307 Cr213 Cr130 Cr110 Cr83 Cr3.26
2024-09-30258 Cr172 Cr116 Cr100 Cr82 Cr3.23
2024-06-30231 Cr166 Cr96 Cr83 Cr61 Cr2.39
2024-03-31253 Cr199 Cr88 Cr71 Cr53 Cr2.10
2023-12-31220 Cr169 Cr78 Cr65 Cr47 Cr1.84
2023-09-30231 Cr145 Cr117 Cr105 Cr80 Cr3.13
2023-06-30348 Cr194 Cr176 Cr164 Cr121 Cr4.74
2023-03-31369 Cr215 Cr178 Cr166 Cr124 Cr4.87

Shareholding Pattern

CURRENT2026-03-31
57.5%PROMOTER
Promoter57.5%
FII5.6%
DII21.8%
Public42.5%
Govt0.0%
PROMOTER HOLDING TREND
50.1%24-0950.1%24-1250.1%25-0366.4%25-0557.5%25-0957.5%25-1257.5%26-03

Corporate Actions

Ex-DateTypePurpose
2024-08-06OtherAnnual General Meeting
2023-12-12OtherAnnual General Meeting
2022-09-09DividendInterim Dividend - Re 1 Per Share/Special Dividend- Rs 5 Per Share
2022-08-11OtherAnnual General Meeting
2022-05-13DividendInterim Dividend - Re 1 Per Share/Special Dividend - Re 1 Per Share
2022-02-15DividendInterim Dividend - Re 1 Per Share/ Special Dividend - Rs 2 Per Share
2021-08-13Dividend Annual General Meeting/Dividend - Re 1 Per Share
2021-02-17Dividend Interim Dividend - Re 1 Per Share
2020-09-25Bonus Bonus 1:1

Earnings Transcripts

Cohance Lifesciences Limited has informed the Exchange about Investor Presentation
12 Nov 2025NSE47K chars
Read →
Cohance Lifesciences Limited has informed the Exchange about Schedule of the results conference call
5 Nov 2025NSE3K chars
Read →
Cohance Lifesciences Limited has informed the Exchange about Investor Presentation
13 Aug 2025NSE36K chars
Read →
Cohance Lifesciences Limited has informed the Exchange about Investor Presentation
28 May 2025NSE45K chars
Read →
Suven Pharmaceuticals Limited has informed the Exchange about Investor Presentation
12 Feb 2025NSE56K chars
Read →
Suven Pharmaceuticals Limited has informed the Exchange about Investor Presentation
29 Feb 2024NSE40K chars
Read →
Suven Pharmaceuticals Limited has informed the Exchange about Investor Presentation
24 Nov 2023NSE28K chars
Read →
Suven Pharmaceuticals Limited has informed the Exchange about Investor Presentation
9 Nov 2023NSE22K chars
Read →
Suven Pharmaceuticals Limited has informed the Exchange about Transcript of Analysts/Institutional I...
15 Nov 2022NSE39K chars
Read →
Suven Pharmaceuticals Limited has informed the Exchange about Transcript of Analysts/Institutional I...
16 Aug 2022NSE36K chars
Read →
Suven Pharmaceuticals Limited has informed the Exchange about Investor Presentation
8 Aug 2022NSE8K chars
Read →
Suven Pharmaceuticals Limited has informed the Exchange about Transcript of Analysts/Institutional I...
8 Jun 2022NSE77K chars
Read →
Suven Pharmaceuticals Limited has informed the Exchange about Transcript of Analysts/Institutional I...
13 May 2022NSE41K chars
Read →
Suven Pharmaceuticals Limited has informed the Exchange about Revised Investor Presentation
9 May 2022NSE8K chars
Read →
Suven Pharmaceuticals Limited has informed the Exchange about Investor Presentation
9 May 2022NSE8K chars
Read →
Suven Pharmaceuticals Limited has informed the Exchange about Investor Presentation
8 Feb 2022NSE9K chars
Read →
Suven Pharmaceuticals Limited has informed the Exchange about Investor Presentation
6 Nov 2021NSE8K chars
Read →
Suven Pharmaceuticals Limited has informed the Exchange about Investor Presentation
16 Aug 2021NSE7K chars
Read →
Suven Pharmaceuticals Limited has informed the Exchange about Investor Presentation
8 Jun 2021NSE7K chars
Read →
Suven Pharmaceuticals Limited has informed the Exchange about Investor Presentation
11 Feb 2021NSE8K chars
Read →

Price History

DateOpenHighLowCloseVolume
2026-04-24365.65369.80355.05360.109.01L
2026-04-23364.45374.85360.50363.9018.35L
2026-04-22364.00372.90360.35362.9014.55L
2026-04-21369.20370.80359.25361.2019.07L
2026-04-20388.00388.00367.00369.2032.08L
2026-04-17362.95406.50359.50390.551.35Cr
2026-04-16360.00365.65354.45362.9513.87L
2026-04-15364.00367.70350.10356.4038.10L
2026-04-13364.80370.60353.15358.6071.12L
2026-04-10321.60380.20318.90377.904.76Cr
2026-04-09309.45325.00306.00316.8513.88L
2026-04-08311.00311.95300.40309.508.92L
2026-04-07302.90306.95296.75300.553.00L
2026-04-02309.60309.65300.30307.252.80L
2026-04-01308.95317.50304.00311.954.98L
2026-03-27305.00309.00296.20302.7010.26L
2026-03-25297.50312.15297.40306.156.45L
2026-03-24307.85307.85293.00296.305.23L
2026-03-20304.25304.25296.05299.255.15L
2026-03-19301.55304.20295.50299.253.34L
2026-03-18304.30309.75300.45306.255.22L
2026-03-17295.45303.00291.25301.257.12L
2026-03-16296.95301.05288.00293.456.04L
2026-03-13286.70303.30283.75296.1015.69L
2026-03-12291.70293.95282.25289.355.69L
2026-03-11295.60312.90288.60291.7017.59L
2026-03-10289.60297.25279.65295.609.08L
2026-03-09275.00285.25266.70282.5510.88L
2026-03-06290.35295.00276.00279.9023.97L
2026-03-05300.50301.75288.10291.856.24L

Frequently Asked Questions

About

Cohance Lifesciences Limited, formerly known as Suven Pharmaceuticals, is an India-based contract development and manufacturing organization (CDMO) offering integrated pharmaceutical services. The company specializes in providing technology-driven solutions for drug development and manufacturing, including formulation development, analytical services, and commercial manufacturing. Notably, Cohance was founded in 1996 and has established itself as a key player in the CDMO sector, serving clients globally.

Advertisement
BOARD OF DIRECTORS

Mutual Fund Holdings

3 funds · bar length = % to NAVBrowse all funds →
hdfc2 schemes
HDFC NIFTY SMALLCAP 250 INDEX FUND
0.29%
₹2 Cr
HDFC Large and Mid Cap Fund
0.15%
₹38 Cr
dsp1 scheme
DSP Regular Savings Fund
0.00%
₹1 Cr